Longeveron to present at H.C. Wainwright 28th Global Investment Conference
Longeveron Inc. said it will participate in the H.C. Wainwright 28th Annual Global Investment Conference.
MIAMI, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc.
NASDAQ:LGVN, a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the H.C.
Wainwright 28th Annual Gl…